Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -240.64% is in line with its 5-year average of -220.73%, around the middle of its 5-year range (-506.93%–-105.60%).
As of the fiscal period ended Tuesday, June 30, 2026. 32.14% below its 12-month average of -182.11%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -240.64%.
RETURN ON INVESTED CAPITAL (ROIC)
-240.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-182.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-191.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-220.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-194.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-32.14%
CURRENT VS 3Y AVG
-25.87%
CURRENT VS 5Y AVG
-9.02%
CURRENT VS 10Y AVG
-23.64%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.80%
median of 696 covered companies
CURRENT VS SECTOR MEDIAN
-611.94%
vs the sector median at left
Adial Pharmaceuticals, Inc.
Market Cap
$11.69M
Return on Invested Capital (ROIC)
-240.64%
TTM Avg
-182.11%
3Y Avg
-191.18%
5Y Avg
-220.73%
Market Cap
$11.62M
Return on Invested Capital (ROIC)
-86.22%
TTM Avg
-227.24%
3Y Avg
-220.51%
5Y Avg
-220.51%
Market Cap
$11.54M
Return on Invested Capital (ROIC)
-127.37%
TTM Avg
-96.60%
3Y Avg
-79.17%
5Y Avg
-74.39%
Market Cap
$11.52M
Return on Invested Capital (ROIC)
-32.27%
TTM Avg
-112.80%
3Y Avg
-113.13%
5Y Avg
-94.20%
Market Cap
$11.44M
Return on Invested Capital (ROIC)
-100.51%
TTM Avg
-100.10%
3Y Avg
-111.41%
5Y Avg
-95.28%
Market Cap
$11.30M
Return on Invested Capital (ROIC)
-59.42%
TTM Avg
-18.05%
3Y Avg
-54.95%
5Y Avg
-57.91%
Market Cap
$11.08M
Return on Invested Capital (ROIC)
-216.67%
TTM Avg
-46.84%
3Y Avg
-98.66%
5Y Avg
-549.86%
Market Cap
$11.36M
Return on Invested Capital (ROIC)
-479.39%
TTM Avg
-317.58%
3Y Avg
-249.47%
5Y Avg
-183.14%
Market Cap
$10.84M
Return on Invested Capital (ROIC)
-204.32%
TTM Avg
-100.17%
3Y Avg
-85.05%
5Y Avg
-71.75%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adial Pharmaceuticals, Inc. (ADIL) | $11.69M | -240.64% | -182.11% | -191.18% | -220.73% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.62M | -86.22% | -227.24% | -220.51% | -220.51% |
| Pluri Inc. (PLUR)vs › | $11.54M | -127.37% | -96.60% | -79.17% | -74.39% |
| Biofrontera Inc. (BFRI)vs › | $11.52M | -32.27% | -112.80% | -113.13% | -94.20% |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.44M | -100.51% | -100.10% | -111.41% | -95.28% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | -59.42% | -18.05% | -54.95% | -57.91% |
| BioVie Inc. (BIVI)vs › | $11.08M | -216.67% | -46.84% | -98.66% | -549.86% |
| Cerenome, Inc. (CNSY)vs › | $11.36M | -479.39% | -317.58% | -249.47% | -183.14% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.84M | -204.32% | -100.17% | -85.05% | -71.75% |
| Dare Bioscience, Inc. (DARE)vs › | $12.54M | -203.50% | -154.20% | -205.70% | -169.89% |
ROIC
-240.6%
ROE
-37052.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -240.64% |
| 2026-03-31 | -202.67% |
| 2025-12-31 | -144.40% |
| 2025-09-30 | -174.35% |
| 2025-06-30 | -148.50% |
| 2025-03-31 | -409.41% |
| 2024-12-31 | -203.65% |
| 2024-09-30 | -138.14% |
| 2024-06-30 | -170.08% |
| 2024-03-31 | -105.60% |
| 2023-12-31 | -168.66% |
| 2023-09-30 | -329.23% |
| 2023-06-30 | -268.25% |
| 2023-03-31 | -506.93% |
| 2022-12-31 | -290.59% |
| 2022-09-30 | -231.32% |
| 2022-06-30 | -180.51% |
| 2022-03-31 | -147.82% |
| 2021-12-31 | -388.80% |
| 2021-09-30 | -197.66% |
| 2021-06-30 | -274.43% |
| 2021-03-31 | -203.68% |
| 2020-12-31 | -274.15% |
| 2020-09-30 | -134.76% |
| 2020-06-30 | -90.48% |
| 2020-03-31 | -149.44% |
| 2019-12-31 | -115.47% |
| 2019-09-30 | -82.98% |
| 2019-06-30 | -92.58% |
| 2019-03-31 | -75.84% |
| 2018-12-31 | -157.32% |
| 2018-09-30 | -122.71% |
| 2017-06-30 | -1937.12% |
| 2016-12-31 | -314.16% |
